Get started
Award

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

Funding type: cooperative_agreement
Funder scheme: UM1
Start date: 2006-06-29
End date: 2016-05-31
Investigator: JAMES DENNIS NEATON
Institution: UNIVERSITY OF MINNESOTA
Funded outputs count: 101
Funder award ID: UM1AI068641
OpenAlex ID: G3598939845
Factors Associated With Persistently Increased IL-6 Levels in People With HIV
2026 · Victoria S Kjærgaard, Bruno Ledergerber, et al. · The Journal of Infectious Diseases
PDF
Early antiretroviral therapy and long-term cancer risk in HIV: 9-year outcomes from the START randomized trial
2026 · Ramya Ramaswami, Jacqueline A. Nordwall, et al. · BMC Cancer · 1
Effect of Delayed Antiretroviral Therapy Initiation on Anti-CD4 Autoantibodies in Antiretroviral Therapy-Naive People With HIV
2026 · Brian P Epling, Shweta Mistry, et al. · The Journal of Infectious Diseases
Proteomic and genetic predictors and risk scores of cardiovascular diseases in persons living with HIV
2026 · Tanvi Mehta, Lillian Haine, et al. · Frontiers in Cardiovascular Medicine · 1
PDF
Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study
2025 · Tomas O. Jensen, Shweta Sharma, et al. · International Journal of Infectious Diseases
Corrigendum to “Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV.” Kidney International 2024;106:136–144
2024 · Annegret Pelchen-Matthews, Amanda Mocroft, et al. · Kidney International
The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants
2024 · Sara Bohnstedt Mørup, Preston Leung, et al. · AIDS Research and Therapy · 1
PDF
Long-term impact of immediate versus deferred antiretroviral therapy on kidney health in people with HIV
2024 · Annegret Pelchen-Matthews, Amanda Mocroft, et al. · Kidney International · 4
Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study
2023 · Alessandro Cozzi‐Lepri, David Dunn, et al. · HIV Medicine · 7
PDF
Derivation of a Protein Risk Score for Cardiovascular Disease Among a Multiracial and Multiethnic HIV+ Cohort
2023 · Sandra E. Safo, Lillian Haine, et al. · Journal of the American Heart Association · 5
PDF
Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort
2023 · Adrian G. Zucco, Marc Bennedbæk, et al. · AIDS · 2
Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV
2023 · David M. MacDonald, Sarah Samorodnitsky, et al. · Scientific Reports · 3
PDF
Faster lung function decline in people living with HIV despite adequate treatment: a longitudinal matched cohort study
2023 · Rebekka Faber Thudium, Andreas Ronit, et al. · Thorax · 29
Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load
2023 · Migle Gabrielaite, Marc Bennedbæk, et al. · PLoS Computational Biology · 8
PDF
The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study
2022 · Ana I Hernández Cordero, Chen Xi Yang, et al. · EBioMedicine · 21
PDF
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels
2021 · ACTIV-3/TICO Bamlanivimab Study Group*, Jens D. Lundgren, et al. · Annals of Internal Medicine · 77
PDF
Phylogenetic analysis of HIV-1 shows frequent cross-country transmission and local population expansions
2021 · Marc Bennedbæk, Anna Zhukova, et al. · Virus Evolution · 8
PDF
Human Immunotypes Impose Selection on Viral Genotypes Through Viral Epitope Specificity
2021 · Migle Gabrielaite, Marc Bennedbæk, et al. · The Journal of Infectious Diseases · 15
Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study
2020 · JD Baxter, D Dunn, et al. · HIV Medicine · 24
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
2020 · ACTIV-3/TICO LY-CoV555 Study Group · New England Journal of Medicine · 433
DNA methylation is associated with airflow obstruction in patients living with HIV
2020 · Ana I Hernandez Cordero, Chen Xi Yang, et al. · Thorax · 33
PDF
The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies
2020 · Christina Ekenberg, Joanne Reekie, et al. · AIDS · 4
Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial: Baseline CVD in START
2020 · Wohl, D, Arastéh, K, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohorts
2020 · Brad T. Sherman, Xiaojun Hu, et al. · AIDS · 14
Occurrence of Accelerated Epigenetic Aging and Methylation Disruptions in Human Immunodeficiency Virus Infection Before Antiretroviral Therapy
2020 · Chen Xi Yang, Emma Schon, et al. · The Journal of Infectious Diseases · 38
PDF
Year
Topic